Table 1. Primary photodynamic therapy with verteporfin for small pigmented choroidal melanoma in 15 patients.
| Features | Number | Percentage |
|---|---|---|
| Age (years) | ||
| Median (mean, range) | 66 (64, 32 to 81) | |
| Gender | ||
| Male | 5 | 33 |
| Female | 10 | 67 |
| Laterality | ||
| Right | 8 | 53 |
| Left | 7 | 47 |
| LogMAR visual acuity in tumor eye | ||
| Median (mean, range) | 0.18 (0.16, −0.08 to 0.48) | |
| LogMAR visual acuity in fellow eye | ||
| Median (mean, range) | 0.00 (0.15, −0.10 to 1.30) | |
| Documented growth | 4 | 27 |
| Number of risk factors for growtha (n=11) | ||
| 3 risk factors—3 | 27 | |
| 4 risk factors—7 | 64 | |
| 5 risk factors—1 | 9 | |
| Symptoms | ||
| Photopsia | 2 | 13.3 |
| Blurred vision | 8 | 53.3 |
| None | 5 | 33.3 |
| Tumor dimensions (mm) | ||
| Median (mean, range) | Height: 1.1 (1.3, 0.9 to 2.7) | |
| Base: 5.0 (4.9, 3.0 to 8.0) | ||
| Distance of tumor from (mm) | ||
| Median (mean, range) | Optic disc: 0.5 (1.3, 0 to 5) | |
| Fovea: 1.5 (1.7, 0 to 4) | ||
| Presence of subretinal fluid | ||
| Above lesion | 13 | 87 |
| Subfovea | 7 | 47 |
| Tumor pigmentation | ||
| 100% | 12 | 80 |
| >50% | 3 | 20 |
| PDT spot size (μm, summary of three sessions) | ||
| Median (mean, range) | 5600 (5139, 3800 to 5600) | |
Patient's demographic and clinical features at presentation and treatment data.
a
Lesion thickness >2 mm, presence of subretinal fluid, presence of lipofuscin, related symptoms, or margin to optic disc ≤3 mm.4